Although TARDBP mutations are extremely rare in ALS patients, TDP-43 aggregates and signalling could explain some of the observed alterations in systemic metabolism—as seen in in vitro studies as stated above. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.